Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.570
-0.380 (-12.88%)
At close: Jul 3, 2025, 1:00 PM
2.560
-0.010 (-0.39%)
After-hours: Jul 3, 2025, 4:39 PM EDT
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $4.78 million as of July 3, 2025. Its market cap has decreased by -9.85% in one year.
Market Cap
4.78M
Enterprise Value
40.16M
1-Year Change
-9.85%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $4.78M, a decrease of -98.28%. That is a compound annual growth rate of -40.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 3.70M | 37.04% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |